Biotechnology Daily
more-
Genmab ditches antibody-drug conjugate after early-phase fizzle
Genmab is pulling the plug on an antibody-drug conjugate it had been developing for solid…
Market Watch
more-
Gold price ends at lowest since mid July, but hangs above key support level at $1,800
Gold dealer’s see the metal’s support level around $1,800 after slipping below $1,850 on Monday
Bio Business News
more
Galapagos sells off Fidelta as CRO activities ‘no longer fit with its strategy’
Galapagos is selling off its contract research organization Fidelta for…
Havn Life Sciences Announces $5.46 Million Warrant Exercise
VANCOUVER, BC – Havn Life Sciences Inc. (CNSX:HAVN)(FSE:5NP) (the “Company” or…
Anti-aging biotech Elevian raises $15M as it looks to the clinic
Early-stage biotech Elevian has raised $15 million as it looks…
World News
more
SpaceX Starlink wins permit to send internet to customers like you
SpaceX has been busy building its Starlink satellite constellation. To…
Facebook video calls soar 1000% during Italy’s lockdown
Facebook has seen usage across its platforms surge in countries…
WeWork board’s special committee is demanding that SoftBank follow through with investment
Five months after SoftBank agreed to a massive bailout of…
Genmab ditches antibody-drug conjugate after early-phase fizzle
Urovant’s vibegron flunks irritable bowel syndrome phase 2
Hoping for an endgame, GSK kick-starts phase 3 RSV vaccine trial in pregnant women
Immunocore’s TCR bispecific improves survival in solid tumor phase 3
Galapagos sells off Fidelta as CRO activities ‘no longer fit with its strategy’
Havn Life Sciences Announces $5.46 Million Warrant Exercise
Anti-aging biotech Elevian raises $15M as it looks to the clinic
FDA Approves Flu Treatment for Preventative Use After Exposure
Gold price ends at lowest since mid July, but hangs above key support level at $1,800
HP shares jump 9% on record PC sales